[HTML][HTML] Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with …
…, P Goss, M Levine, W Parulekar, J Pater, E Rakovitch… - The lancet, 2019 - thelancet.com
Background Increasing the dose intensity of cytotoxic therapy by shortening the intervals
between cycles, or by giving individual drugs sequentially at full dose rather than in lower-dose …
between cycles, or by giving individual drugs sequentially at full dose rather than in lower-dose …
Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases
…, N Laperriere, A Sahgal, E Rakovitch… - Cochrane Database …, 2018 - cochranelibrary.com
Background This is an update to the review published in the Cochrane Library (2012, Issue
4).
4).
[HTML][HTML] RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation
…, C Hudis, HM Kuerer, E Rakovitch… - Journal of Clinical …, 2015 - ncbi.nlm.nih.gov
Purpose The Radiation Therapy Oncology Group 9804 study identified good-risk patients
with ductal carcinoma in situ (DCIS), a breast cancer diagnosis found frequently in …
with ductal carcinoma in situ (DCIS), a breast cancer diagnosis found frequently in …
Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography
…, S Lemon-Wong, JP Pignol, E Rakovitch… - Translational …, 2013 - Elsevier
PURPOSE: Ultrasound elastography is a new imaging technique that can be used to
assess tissue stiffness. The aim of this study was to investigate the potential of ultrasound …
assess tissue stiffness. The aim of this study was to investigate the potential of ultrasound …
Multigene expression assay and benefit of radiotherapy after breast conservation in ductal carcinoma in situ
E Rakovitch, S Nofech-Mozes, W Hanna… - JNCI: Journal of the …, 2017 - academic.oup.com
Background: Most women with ductal carcinoma in situ (DCIS) will receive breast-conserving
surgery (BCS) and radiation (RT). RT can be omitted for women at low risk of local …
surgery (BCS) and radiation (RT). RT can be omitted for women at low risk of local …
[PDF][PDF] A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis
JP Pignol, I Olivotto, E Rakovitch… - Journal of Clinical …, 2008 - researchgate.net
Purpose Dermatitis is a frequent adverse effect of adjuvant breast radiotherapy. It is more
likely in full-breasted women and when the radiation is distributed nonhomogeneously in the …
likely in full-breasted women and when the radiation is distributed nonhomogeneously in the …
[HTML][HTML] Omitting radiotherapy after breast-conserving surgery in luminal A breast cancer
…, AW Fyles, A Bane, FF Liu, E Rakovitch… - … England Journal of …, 2023 - Mass Medical Soc
Background Adjuvant radiotherapy is prescribed after breast-conserving surgery to reduce
the risk of local recurrence. However, radiotherapy is inconvenient, costly, and associated …
the risk of local recurrence. However, radiotherapy is inconvenient, costly, and associated …
[HTML][HTML] A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone
E Rakovitch, S Nofech-Mozes, W Hanna… - Breast cancer research …, 2015 - Springer
Validated biomarkers are needed to improve risk assessment and treatment decision-making
for women with ductal carcinoma in situ (DCIS) of the breast. The Oncotype DX ® DCIS …
for women with ductal carcinoma in situ (DCIS) of the breast. The Oncotype DX ® DCIS …
Quality of life (QOL) and symptom burden (SB) in patients with breast cancer
…, R Chow, C DeAngelis, J Ellis, E Rakovitch… - Supportive Care in …, 2017 - Springer
Purpose The purpose of this study was to determine the quality of life (QOL) and symptom
burden (SB) among breast cancer patients. Methods Patients with DCIS, early stage, locally …
burden (SB) among breast cancer patients. Methods Patients with DCIS, early stage, locally …
Radiotherapeutic management of brain metastases: a systematic review and meta-analysis
MN Tsao, NS Lloyd, RKS Wong, E Rakovitch… - Cancer treatment …, 2005 - Elsevier
BACKGROUND: The management of brain metastases is a significant health care problem.
An estimated 20–40% of cancer patients will develop metastatic cancer to the brain during …
An estimated 20–40% of cancer patients will develop metastatic cancer to the brain during …
